Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 2:00 PM
Ignite Modification Date: 2025-12-25 @ 12:46 PM
NCT ID: NCT00637195
Description: None
Frequency Threshold: 5
Time Frame: From Month 0 up to Month 13.
Study: NCT00637195
Study Brief: Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Engerix™ Group Subjects received 4 doses of Hepatitis B (HBV) vaccine (Months 0, 1, 2 \& 12). None None 2 76 73 76 View
Cervarix™ & Engerix™ Group Subjects received 3 doses of GSK Biologicals' HPV vaccine (580299) (Cervarix™) (Months 0, 1 \& 6) and 4 doses of Hepatitis B (Engerix™) vaccine (Months 0, 1, 2 \& 12). None None 2 76 76 76 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Abortion spontaneous complete NON_SYSTEMATIC_ASSESSMENT Pregnancy, puerperium and perinatal conditions MedDRA 10.0 View
Graves-Basedow's disease NON_SYSTEMATIC_ASSESSMENT Endocrine disorders MedDRA 10.0 View
Endometriosis NON_SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA 10.0 View
Gastroenteritis viral NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 10.0 View
Type 1 diabetes mellitus NON_SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 10.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Pain at injection site SYSTEMATIC_ASSESSMENT General disorders MedDRA 10.0 View
Redness at injection site SYSTEMATIC_ASSESSMENT General disorders MedDRA 10.0 View
Swelling at injection site SYSTEMATIC_ASSESSMENT General disorders MedDRA 10.0 View
Arthralgia SYSTEMATIC_ASSESSMENT General disorders MedDRA 10.0 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA 10.0 View
Gastrointestinal symptom SYSTEMATIC_ASSESSMENT General disorders MedDRA 10.0 View
Headache SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 10.0 View
Myalgia SYSTEMATIC_ASSESSMENT General disorders MedDRA 10.0 View
Rash SYSTEMATIC_ASSESSMENT General disorders MedDRA 10.0 View
Temperature SYSTEMATIC_ASSESSMENT General disorders MedDRA 10.0 View
Headache NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 10.0 View
Upper respiratory tract infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 10.0 View
Dysmenorrhoea NON_SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA 10.0 View
Cystitis NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 10.0 View
Nasopharyngitis NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 10.0 View
Oropharyngeal pain NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 10.0 View
Rhinitis NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 10.0 View
Abdominal pain NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 10.0 View
Cough NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 10.0 View
Influenza like illness NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA 10.0 View
Pharyngitis NON_SYSTEMATIC_ASSESSMENT Immune system disorders MedDRA 10.0 View